Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis

Luca Richeldi, Harold R. Collard, Roland M. du Bois, Gisli Jenkins, Martin Kolb, Toby M. Maher, Ganesh Raghu, Carlo Vancheri, Geoffrey J. Laurent
European Respiratory Journal 2013 42: 230-238; DOI: 10.1183/09031936.00038613
Luca Richeldi
1Centre for Rare Lung Diseases, University of Modena and Reggio Emilia, Modena
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • For correspondence: luca.richeldi@unimore.it
Harold R. Collard
2University of California, San Francisco, CA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Roland M. du Bois
3Imperial College London, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gisli Jenkins
4University of Nottingham, Nottingham
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Martin Kolb
5Dept of Respiratory Medicine, Pathology and Molecular Medicine, McMaster University, Hamilton, Canada
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Toby M. Maher
6Interstitial Lung Disease Unit, Royal Brompton Hospital and National Heart and Lung Institute, Imperial College London, London
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ganesh Raghu
7Division of Pulmonary and Critical Care Medicine, University of Washington, Seattle, WA, USA
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Carlo Vancheri
8Dept of Internal Medicine, University of Catania, Catania, Italy
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Geoffrey J. Laurent
9University of Western Australia, All authors were members of the scientific committee of the 17th ICLAF meeting, Perth, Australia
10University College London, London, UK
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Figures

  • Additional Files
  • Figure 1–
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 1–

    Key research steps in pulmonary fibrosis.

  • Figure 2–
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 2–

    Schematic pathogenic steps in pulmonary fibrosis (as discussed during the 2012 ICLAF). Th: T-helper cell; CTGF: connective tissue growth factor; TGF: transforming growth factor; PDGF: platelet-derived growth factor; ROCK: Rho-associated protein kinase; NOX: NADPH oxidase; LOXL: lysyl oxidase; S1P–S1P1: sphingosine-1-phosphate–sphingosine-1-phosphate receptor 1; mTOR: mammalian target of rapamycin; EMT: epithelial–mesenchymal transition.

  • Figure 3–
    • Download figure
    • Open in new tab
    • Download powerpoint
    Figure 3–

    Collective efforts lead to improved outcomes for patients with pulmonary fibrosis. FDA: Food and Drug Administration; EMA: European Medicines Agency.

Additional Files

  • Figures
  • Files in this Data Supplement:

    • H.R. Collard
    • R.M. du Bois
    • G. Jenkins
    • M. Kolb
    • G.J. Laurent
    • T.M. Maher
    • G. Raghu
    • L. Richeldi
    • C. Vancheri
PreviousNext
Back to top
View this article with LENS
Vol 42 Issue 1 Table of Contents
European Respiratory Journal: 42 (1)
  • Table of Contents
  • Table of Contents (PDF)
  • About the Cover
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Print
Citation Tools
Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis
Luca Richeldi, Harold R. Collard, Roland M. du Bois, Gisli Jenkins, Martin Kolb, Toby M. Maher, Ganesh Raghu, Carlo Vancheri, Geoffrey J. Laurent
European Respiratory Journal Jul 2013, 42 (1) 230-238; DOI: 10.1183/09031936.00038613

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Mapping the future for pulmonary fibrosis: report from the 17th International Colloquium on Lung and Airway Fibrosis
Luca Richeldi, Harold R. Collard, Roland M. du Bois, Gisli Jenkins, Martin Kolb, Toby M. Maher, Ganesh Raghu, Carlo Vancheri, Geoffrey J. Laurent
European Respiratory Journal Jul 2013, 42 (1) 230-238; DOI: 10.1183/09031936.00038613
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo
Full Text (PDF)

Jump To

  • Article
    • Abstract
    • ICLAF: a long journey
    • Invited lectures
    • Invited oral presentations
    • Future directions in pulmonary fibrosis research
    • Closing comments
    • Acknowledgments
    • Footnotes
    • References
  • Figures & Data
  • Info & Metrics
  • PDF
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • The physiological basis of pulmonary arterial hypertension
  • The role of circular RNAs in pulmonary hypertension
  • The paradox of immune checkpoint inhibition reactivating tuberculosis
Show more Review

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society